Porto sinusoidal vascular liver disease (PSVD) is a vascular liver disease characterized by portal hypertension in the absence of cirrhosis and other causes of liver disease[1]. 门窦性血管性肝病(PSVD)是一种以血管性肝病为特征的门静脉高压,...
发病机制 到目前为止,INCPH 的具体病理生理机制尚不 明确。分二元理论和统一理论 二元理论: 认为,肝内血管闭塞所致 门静脉血流阻力增加和脾大继发门静脉血流增加是 导致 INCPH 患者门静脉高压的两个主要因素。肝 内血管闭塞的具体原因尚不清楚 统一理论:...
INCPH 在世界各地都有报道,它在西方较为罕 见,而在发展中国家,其发病率更高。性别比例在不同国家有所不同,在西方国家和印度多见于男 性,而在日本则多发于女性。发病年龄不定,在印度,其发病年龄约 25 ~ 35 岁,在日本,其发病年龄约 50 岁,而 在 西...
肝癌是全世界范围内常见的消化系统恶性肿瘤,我国肝癌的发病率和死亡率在恶性肿瘤中分别排列第4位和第2位。肝癌具有早诊困难、进展迅速,预后较差等特征, 特别是对于中晚期肝癌患者的治疗选择非常有限。 一项2期临床试验评估了钇90微球疗法联合免疫药物Opdiv...
Optimal stent diameter The 8-mm vs 10-mm debate: The availability of covered stents for TIPS has significantly reduced the incidence of stent dysfunction with attendant improvement in patient outcomes[206]. 最佳支架直径 8mm和10mm的争论:覆...
为什么? 因为:静脉曲张出血的继发性预防:在急性静脉曲张出血后存活下来的患者有再出血和死亡的高风险。未经治疗的患者的1年的VH复发率约为60%,死亡率接近30%【1】 表:已经报告防止静脉曲张再出血不同治疗的随机对照死亡率和再出血率 EIS=endoscopic inj...
Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and mortality. 门脉高压的并发症,包括腹水、胃肠出血、肝性胸水和...
In patients who have gastro-oesophageal variceal bleeding refractory to endoscopic and drug therapy as defined by Baveno 6 critera,32 transjugular intrahepatic portosystemic stent-shunt (TIPSS) is recommended (strong recommendation, modera...
The role of early or pre-emptive TIPSS in acute variceal bleeding in view of the conflicting evidence and uncertainly about patient selection. 鉴于相互矛盾的证据和不确定的患者选择,早期或先发制人的TIPSS在急性静脉曲张出血中的作用。 Large mu...
Abstract These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gast...
门静脉系统因狭窄(24%)或闭塞(12%)导致减压丧失 复发性门静脉高压症; 静脉曲张的出血;...
肝细胞癌(HCC)是癌症死亡的重要原因,被认为是世界上第三大致命疾...
局部治疗联合免疫治疗原理...
经导管动脉化疗性栓塞(Transcatheter arterial chemotherapy,TACE)是一种治疗肝脏...
超早期肝癌(0期)不能肝移植 消融(全身治疗辅助?)>5年生存如果失败或不可行TACE...
单纯肝动脉栓塞的背景 Bland embolisation: Background 肝癌单纯栓塞(Bland emboliza...